Bax protein expression correlates with radiation-induced apoptosis in radiation therapy for cervical carcinoma

Cancer

Volumn 83, Issue 1, 1998, Pages 103-110

  Ohno, Tatsuya ^a,b   Nakano, Takashi ^a   Niibe, Yuzuru ^a   Tsujii, Hirohiko ^a   Oka, Kuniyuki ^c  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c Mito Saiseikai General Hospital   (Japan)

Author keywords

Apoptosis; Bax; Bcl 2; Cervical carcinoma; Radiation therapy

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE FRACTIONATION; UTERINE CERVIX CARCINOMA;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; FEMALE; HUMANS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; UTERINE CERVICAL NEOPLASMS;

EID: 0032126465     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980701)83:1<103::AID-CNCR14>3.0.CO;2-0     Document Type: Article

References (41)

1. Kerr JFR, Wylie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
2. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994; 73:2013-6.
3. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985; 229:1390-3.
4. Vaux DL, Cory S, Adams JM. bcl-2 promotes the survival of haemopoietic cells and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335: 440-2.
5. Hockenbery D, Nunetz G, Milliman C, Schreiber RD, Korsmeyer SJ. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
6. Korsmeyer S. bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
7. McDonnell TJ, Korsmeyer SI. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the (14;18). Nature 1991;349:254-6.
8. Sinicrope FA, Hart I, Michelassi FM. Lee JJ. Prognostic value of bcl-2 oncoprotein expression in Stage II colon carcinoma. Clin Cancer Res 1995;1:1103-10.
9. Joensuu H, Pylkkanen L, Toikkanen S. bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994;145:1191-8.
10. Colombel M, Symmans F, O'Toole KM, Chopin D, Benson M, Olsson CA, et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers. Am J Pathol 1994;144:1195-202.
11. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnil MS, Pierce CB, et al. bcl-2 protein in non-small cell lung carcinoma. N Engl J Med 1993;349:690-4.
12. Harmsel BT, Smedts F, Kuijpers J, Jeunink M, Trimbos B, Ramaekers F. bcl-2 immunoreactivitv increases with severity of CIN: a study of normal cervical epithelia, CIN, and cervical carcinoma. J Pathol 1996;179:26-30.
13. Saegusa M, Takano Y, Hashimura M, Shouji Y, Okayasu I. The possible role of bcl-2 expression in the progression of tumors of uterine cervix. Cancer 1995;76:2297-303.
14. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, et al. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 1995;374:731-3.
15. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, et al. Induction of apoptosis by the bcl-2 homologue Bak. Nature 1995;374:733-6.
16. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, et al. Modulation of apoptosis by the widely distributed bcl-2 homologue Bak. Nature 1995;374:736-9.
17. L. Nature 1996;379:554-6.
18. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of bcl-2. Am J Pathol 1994;145:1323-36.
19. Kernohan NM, Cox LS. Regulation of apoptosis by bcl-2 and its related proteins: immunochemical challenges and therapeutic implications. J Pathol 1996;179:1-3.
20. Oltvai ZN, Milliman CL, Korsmeyer SJ. bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 1993;74:609-19.
21. Brambilla E, Negoescu A, Gazzeri S, Lantuejoul DM, Brambilla C, Coll J-L. Apoptosis-related factors p53, bcl-2, and Bax in neuroendocrine lung tumors. Am J Pathol 1996;149:1941-52.
22. Jiang M-C, Yang-Yen H-F, Lin J-K, Yen JJ-Y. Differential regulation of p53, c-myc, bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 1996;13:609-16.
23. Sakakura C, Sweeney EA, Shirahama T, Igarashi Y, Hakomori S, Nakatani H, et al. Overexpression of Bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis. Int J Cancer 1996;67:101-5.
24. Thomas A, Rouby SE, Reed JC, Krajewski S, Silber R, Potmesil M, et al. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 1996; 12:1055-62.
25. Radford IR, Murphy TK. Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double strand breakage. Int J Radiat Oncol Biol Phys 1994;65:229-39.
26. Hopcia KL, McCarey YL, Sylvester C, Held KD. Radiation-induced apoptosis in HL60 cells: oxygen effect, relationship between apoptosis and loss of clonogenicity, and dependence of time to apoptosis on radiation dose. Radiat Res 1996;145:315-23.
27. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995;33:781-96.
28. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in carcinoma of the uterus, vagina and ovary. Volume 16. Sweden: Radiumhemmet, 1979.
29. Poulsen HE, Taylor CW, Sobin LH. Histological typing of female genital tract tumors. No.13. Geneva: World Health Organization, 1975.
30. Arai T, Nakano T, Morita S, Sakashita S, Nakamura Y, Fukuhisa K. High dose rate remote afterloading intracavity radiation therapy for cancer of the uterine cervix: a 20-year experience. Cancer 1992;69:175-80.
31. Searle J, Collin DI, Harmon B, Kerr JFR. The spontaneous occurrence of apoptosis in squamous cell carcinomas of the uterine cervix. Pathology 1973;5:163-9.
32. Levine EL, Davidson SE, Roberts SA, Chadwick CA, Potten CS, West CML. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet 1994;344:472.
33. Hori M, Hasegawa H, Koizumi S, Ono H, Nakayama H. Detection of DNA strand breaks associated with apoptotic cell death in human breast cancer. Jpn J Cancer Clin 1996; 42:717-22.
34. Potten CS. What is an apoptotic index measuring? A commentary. Br J Cancer 1996;74:1743-8.
35. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA, Milas L. Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int J Radiat Oncol Biol Phys 1993;64:583-91.
36. Hasegawa M, Niibe H. Radiation-induced apoptosis (1). Jpn J Cancer Clin 1995;41:663-7.
37. Wheeler JA, Stephens LC, Torno C, Eifel PJ, Ang KK, Milas L, et al. Astro research fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1487-93.
38. Kitada S, Krajewski S, Miyashita T, Krajewska M, Reed JC. Radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 1996;12:187-92.
39. Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995;270:96-9.
40. Butz K, Geisen C, Ullmann A, Spitkovsky D, Hoppe SF. Cellular response of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis. Int J Cancer 1996;68:506-13.
41. Han Z, Chatterjee D, He DM, Early J, Pantazis P, Wyche JH, et al. Evidence for a G2 checkpoint in p53-independent apoptosis induction by x-irradiation. Mol Cell Biol 1995;15: 5849-57.